技术文章

The Skin Anti-Aging Mechanisms of α-Lipoic Acid: ALA/DHLA Redox Cycling, the Antioxidant Network, and Regulation of Collagen AGE Formation

1. The Chemical Basis Behind Dullness, Roughness, and Loss of Skin Elasticity

 

1.1 “Glycation Face” as a Manifestation of Glycation-Related Aging

“Glycation face” or “sugar face” is commonly used to describe skin conditions such as dull yellowish tone, rough texture, reduced elasticity, more visible fine lines, and diminished radiance. These visible changes reflect aging manifestations that arise from the combined involvement of glycation reactions, oxidative stress, inflammatory signaling, and structural changes in collagen within the skin.

 

At the core of glycation is a non-enzymatic reaction between reducing sugars or reactive carbonyl compounds and amino groups on proteins, lipids, or nucleic acids, ultimately leading to the formation of AGEs, or advanced glycation end products. In the skin, AGEs can affect collagen, elastin, keratinocytes, fibroblasts, and skin barrier function, and are associated with yellowing of the skin, reduced elasticity, and deeper wrinkles.

 

1.2 Glycation and Oxidation Jointly Drive AGE Formation

Skin glycation is not a single reaction, but a series of slow chemical changes. It begins with early-stage reversible reactions and gradually progresses into more stable, more difficult-to-reverse crosslinking stages.

 

Reducing sugar + protein-NH2

↓

Schiff base

↓

Amadori product

↓ Oxidation, dehydration, cleavage

Reactive dicarbonyl compounds: MGO (methylglyoxal); GO (glyoxal); 3-DG (3-deoxyglucosone)

↓

AGE formation

↓

Protein crosslinking, denaturation, and functional decline

 

During the glycation process, oxidative stress accelerates the conversion of intermediate products into AGEs. Metal ion-catalyzed oxidation reactions can also increase the generation of reactive carbonyl compounds. Skin glycation-related aging is therefore the result of glycation stress and oxidative stress acting together on structural proteins in the skin.

 

2. The Essence of Collagen Aging: Abnormal Crosslinking Makes Elastic Structures Stiffer

 

2.1 Collagen Aging Is Not Simply a Reduction in Quantity, but a Decline in Structural Quality

Collagen is the main structural scaffold of the dermis. A young collagen network has a certain degree of extensibility, sliding capacity, and rebound ability. Whether the skin appears firm and elastic depends not only on the amount of collagen, but also on whether collagen fibers maintain normal alignment and mechanical mobility.

 

AGEs can form abnormal crosslinks between collagen molecules, turning an originally flexible collagen network into a stiffened structure. This process can be understood as the gradual fixation of collagen architecture.

 

Normal collagen network

Collagen fiber —— Collagen fiber —— Collagen fiber

Extensible   Able to slide     Able to rebound

 

Collagen network after AGE crosslinking

Collagen fiber == AGE crosslink == Collagen fiber == AGE crosslink == Collagen fiber

Restricted sliding   Reduced elasticity   Structural stiffness

 

Skin collagen is a low-turnover, long-lived structural protein with a relatively slow renewal rate. Once AGEs, or advanced glycation end products, accumulate in collagen, they may cause long-term changes in the structural stability and mechanical properties of the dermal matrix. Studies show that AGEs such as CML (carboxymethyllysine), CEL (carboxyethyllysine), and pentosidine in skin collagen increase with age. Among them, CML and CEL are commonly used as non-crosslinking glycation markers, while pentosidine is a typical fluorescent crosslinking AGE. Because collagen renews slowly and remains in the skin for a long time, it is exposed to glycation and oxidation environments over extended periods. This is an important reason why AGEs can gradually accumulate in skin collagen.

 

2.2 How Collagen Crosslinking Manifests as Dullness, Roughness, and Fine Lines

Some AGEs have fluorescent and yellow-brown characteristics. AGE accumulation can cause collagen browning, making the skin appear more yellow and dull. AGEs can also affect collagen fiber arrangement and the balance of collagen degradation, reducing dermal elasticity and making the skin surface more prone to roughness and fine lines.

 

AGEs can also bind to RAGE, the receptor for advanced glycation end products, and induce responses related to ROS (reactive oxygen species), inflammatory signaling, and MMPs (matrix metalloproteinases), further aggravating collagen structural damage.

 

Increased AGEs → Abnormal collagen crosslinking → Restricted sliding of collagen fibers → Reduced dermal elasticity → Dullness, roughness, fine lines, and reduced rebound

 

3. The Structural Basis of α-Lipoic Acid: Carboxyl Group, Carbon Chain, and Disulfide Ring

 

3.1 What Is α-Lipoic Acid?

α-Lipoic acid, abbreviated as ALA, is also known as lipoic acid or thioctic acid. It is an endogenous sulfur-containing compound found in the human body and a disulfide derivative of octanoic acid. It acts as a cofactor in mitochondrial energy metabolism and can also participate in redox regulation.

 

Its chemical name is 5-(1,2-dithiolan-3-yl)pentanoic acid. Its simplified structure is shown below:

 

 

 

HOOC-(CH2)4-CH-(1,2-dithiolane ring)

Where:

HOOC- Carboxylic acid group

-(CH2)4- Hydrophobic carbon chain

1,2-dithiolane ring Five-membered disulfide ring containing two sulfur atoms

 

3.2 Its Structure Determines Three Fundamental Capabilities

 

Molecular structure

Chemical feature

Corresponding capability

Carboxylic acid group -COOH

Polar, ionizable

Provides hydrophilicity, allowing the molecule to interact with aqueous environments

Carbon chain -(CH2)4-

Nonpolar, hydrophobic

Provides lipophilicity, allowing the molecule to enter lipid environments

Disulfide ring -S-S-

Can be reduced to two thiol groups

Forms the ALA/DHLA redox cycle and serves as the active core

 

The antioxidant characteristics of α-lipoic acid come from the combined action of these three structural components:

the carboxyl group provides polarity and ionizable properties, allowing the molecule to interact with aqueous environments; the carbon chain and sulfur-containing five-membered ring provide hydrophobic characteristics, giving it the structural basis to enter lipid environments; and the disulfide bond enables participation in electron transfer.

 

4. The Active Core: The ALA/DHLA Redox Cycle

 

4.1 The Disulfide Bond Is a Reversible Redox Switch

The five-membered disulfide ring of ALA can be reduced to form DHLA, or dihydrolipoic acid. This process can be represented by a simplified half-reaction:

ALA + 2H⁺ + 2e⁻ ⇌ DHLA

 

In essence, the disulfide bond accepts two electrons and two protons, opens the ring, and forms two thiol groups:

R-S-S-R′ + 2H⁺ + 2e⁻ ⇌ R-SH + HS-R′

 

ALA:

HOOC-(CH2)4-CH-(1,2-dithiolane ring)

 

DHLA:

HOOC-(CH2)4-CH(SH)-CH2-CH2-SH

 

4.2 ALA/DHLA Acts as an Electron-Transfer Node in the Antioxidant Network

ALA and DHLA form a redox pair. After ALA accepts electrons, it is converted into DHLA, and DHLA can then transfer its reducing capacity to other oxidized molecules. This feature means that it does not merely scavenge free radicals on its own, but can also participate in regeneration cycles among antioxidants.

 

ALA ⇌ DHLA

Oxidized form ⇌ Reduced form

 

The ALA/DHLA system can scavenge certain reactive species, chelate metal ions, and influence antioxidant systems involving vitamin C, vitamin E, and GSH (glutathione). The disulfide bond is the core structure through which α-lipoic acid exerts its redox activity.

 

5. Distribution Advantage: Connecting Aqueous and Lipid Phases

 

5.1 Oxidative Reactions in the Skin Occur in Different Regions

 

Skin region

Environmental feature

Main oxidative risks

Cytoplasm, extracellular fluid, dermal interstitial fluid

Aqueous environment

ROS reactions, protein oxidation, ascorbic acid depletion

Cell membranes, lipid bilayers, sebum film

Lipid environment

Lipid peroxidation, membrane structural damage

Mitochondria and metabolically active regions

Redox reactions are intensive

Electron leakage, ROS generation

 

5.2 The Amphiphilic Nature of α-Lipoic Acid Comes from Its Molecular Structure

ALA contains both hydrophilic and lipophilic structural features.

Hydrophilic end: carboxylic acid group -COOH

Lipophilic end: carbon chain + sulfur-containing five-membered ring

 

Oxidative damage in the skin does not occur in only one location. Aqueous environments require water-soluble antioxidants, while lipid membranes and the sebum film require lipid-soluble antioxidant protection. What makes α-lipoic acid distinctive is that its amphiphilic structure allows it to participate in both aqueous and lipid environments, while the ALA/DHLA redox pair helps connect different antioxidant systems.

 

Ingredient

Main solubility feature

Main area of action

Antioxidant role

Vitamin C

Water-soluble

Aqueous environments such as the cytoplasm, extracellular fluid, and dermal interstitial fluid

Scavenges certain water-phase ROS (reactive oxygen species) and participates in the regeneration of oxidized vitamin E

Vitamin E

Lipid-soluble

Lipid environments such as cell membranes, the sebum film, and lipid bilayers

Captures lipid peroxyl radicals and interrupts lipid peroxidation chain reactions

α-Lipoic acid

Amphiphilic

Can participate in both aqueous and lipid phases

Through the ALA/DHLA redox pair, connects aqueous-phase antioxidation, lipid-phase antioxidation, and the intracellular GSH (glutathione) reducing system

 

The aqueous-lipid dual-phase characteristics of ALA do not mean that it is highly stable or highly soluble in every formulation. Topical skincare products still need to consider solvent systems, pH, light protection, antioxidant protection, and packaging stability. The advantage of ALA lies in the fact that its structure provides a basis for participation in redox reactions across aqueous and lipid phases.

 

6. The Antioxidant Network: Linking Free Radicals, Metal Ions, Vitamin C, Vitamin E, and GSH

 

6.1 First Layer: Reducing ROS/RNS Attacks on Proteins and Lipids

ALA/DHLA can react with various ROS and RNS (reactive nitrogen species), including hydroxyl radicals, superoxide radicals, peroxyl radicals, singlet oxygen, nitric oxide radicals, peroxynitrite, and hypochlorous acid. It should be noted that ALA and DHLA do not have identical reactivity toward different reactive species, and DHLA generally has stronger reducing capacity.

 

Increased ROS/RNS → Lipid peroxidation, protein oxidation, DNA damage → Glycation intermediates become more susceptible to oxidation and rearrangement → Increased pressure for AGE formation

 

By reducing oxidative stress, ALA/DHLA can decrease the conditions that drive glycation reactions further toward AGE formation.

 

6.2 Second Layer: Chelating Certain Transition Metal Ions to Reduce Metal-Catalyzed Oxidative Stress

Transition metal ions such as iron and copper can catalyze free radical generation. A typical example is the Fenton reaction:

 

Fe²⁺ + H₂O₂ → Fe³⁺ + ·OH + OH⁻

Here, ·OH is the hydroxyl radical, which is highly reactive and can attack lipids, proteins, and nucleic acids, leading to lipid peroxidation, protein oxidation, and cellular structural damage.

 

The metal-chelating capacity of ALA/DHLA is related to its sulfur atoms and carboxyl group. It is important to distinguish between ALA (α-lipoic acid) and DHLA (dihydrolipoic acid), as their metal-binding characteristics are not exactly the same: DHLA can chelate various metal ions such as Fe³⁺, Cu²⁺, Zn²⁺, Pb²⁺, and Hg²⁺; ALA can bind metal ions such as Mn²⁺, Cu²⁺, Zn²⁺, and Pb²⁺, but has relatively weak chelating ability toward Fe³⁺. Metal chelation does not mean depletion of metal elements in the skin; rather, it reduces the opportunity for free metal ions to participate in redox catalysis, thereby reducing metal-catalyzed oxidative stress.

 

Fe/Cu and other metal ions → Catalyze ROS generation → Increased lipid peroxidation and protein oxidation → Glycation intermediates more readily convert into AGEs

 

ALA/DHLA chelates some metal ions → Reduced metal-catalyzed oxidative stress → Reduced promoting factors for AGE formation

 

6.3 Third Layer: Helping Vitamin C and Vitamin E Enter Regeneration Cycles

Vitamin E is mainly present in lipid environments, such as cell membranes, lipid bilayers, and the sebum film. Its core function is to protect lipid structures. When lipids are attacked by oxidation, lipid peroxyl radicals are generated; vitamin E can preferentially react with these radicals, blocking the further spread of lipid peroxidation and thereby protecting cell membranes and skin lipid structures.

 

During this process, vitamin E “gives away” its reducing capacity and changes from its active state into an oxidized vitamin E radical. In other words, after vitamin E completes one round of antioxidant protection, it temporarily loses part of its antioxidant capacity.

 

At this point, vitamin C can participate in repair. Vitamin C is mainly present in aqueous environments, where it can reduce oxidized vitamin E back to its active form, allowing vitamin E to continue protecting lipid membranes. This process reflects the synergy between aqueous-phase and lipid-phase antioxidants: vitamin E intercepts lipid radicals in the lipid phase, while vitamin C helps regenerate vitamin E in the aqueous phase.

 

What is distinctive about α-lipoic acid is that its reduced form, DHLA (dihydrolipoic acid), can further support the vitamin C system. DHLA has reducing capacity and can help restore oxidized vitamin C to its reduced state, allowing vitamin C to continue participating in antioxidant cycling. In this way, DHLA, vitamin C, and vitamin E form a continuous antioxidant regeneration chain.

 

This process can be understood as follows:

DHLA helps vitamin C restore its reducing capacity;

Vitamin C helps vitamin E regain activity;

Vitamin E continues to protect lipid membranes and block lipid peroxidation.

 

6.4 Fourth Layer: Supporting the GSH System and Maintaining the Cellular Reducing State

GSH (glutathione) is an important intracellular reducing system composed of glutamic acid, cysteine, and glycine. It participates in peroxide clearance, maintains the thiol status of proteins, and helps cells preserve a reducing environment.

 

ALA may increase or maintain intracellular GSH levels by promoting the expression of genes related to GSH synthesis and increasing substrate availability. ALA/DHLA may also support the cellular antioxidant state by influencing the GSH/GSSG ratio, where GSSG refers to glutathione disulfide, the oxidized form of glutathione.

 

GSH is also involved in the metabolism of dicarbonyl compounds. MGO is an important reactive dicarbonyl compound involved in AGE formation, and the human body can process MGO through the glyoxalase system. This system involves GLO1 (glyoxalase 1), GLO2 (glyoxalase 2), and GSH. By supporting the GSH/GSSG status and the cellular reducing environment, ALA may theoretically help cells respond to carbonyl stress from compounds such as MGO.

 

MGO is a reactive carbonyl compound that readily promotes glycation

↓

GSH first binds with MGO to form a temporary intermediate

↓

GLO1 and GLO2 sequentially process this intermediate

↓

MGO is converted into D-lactate

↓

GSH is released and continues to participate in the cellular redox cycle

 

6.5 Mechanistic Overview

 

Layer of action

α-Lipoic acid-related structure

Main mechanism

Relationship to anti-glycation

Free radical scavenging

ALA/DHLA redox pair

Neutralizes certain ROS/RNS

Reduces oxidation, rearrangement, and crosslinking of glycation intermediates

Metal chelation

Sulfur atoms + carboxyl group

Reduces opportunities for Fe/Cu and other metals to catalyze oxidation

Reduces metal-catalyzed glycoxidation and protein oxidation

Vitamin C / vitamin E regeneration

Reducing capacity of DHLA

Helps maintain vitamin C in its reduced form and indirectly supports the vitamin E cycle

Maintains antioxidant continuity between aqueous and lipid phases

GSH support

ALA regulation of cellular redox state

Maintains GSH/GSSG balance and supports cellular antioxidant defense

Indirectly supports the handling of MGO and other carbonyl stresses

Aqueous-lipid dual-phase distribution

Carboxyl group + carbon chain + disulfide ring

Connects aqueous phases, lipid phases, and intracellular reducing systems

Covers a broader range of oxidative damage regions

 

7. Skincare Application: The Practical Value of α-Lipoic Acid in Anti-Glycation and Anti-Aging

 

7.1 Point of Intervention: Reducing the Environmental Pressure That Drives Continued Glycation

When α-lipoic acid is used in anti-aging skincare, the focus is not on directly eliminating already-formed AGEs, but on reducing the oxidative environment and catalytic conditions required for glycation to continue progressing.

 

Already-formed AGE crosslinks are generally relatively stable, and collagen is a low-turnover, long-lived structural protein. The more realistic role of topical α-lipoic acid is to help reduce new oxidative damage, metal-catalyzed oxidation, and carbonyl stress, thereby lowering the risk of continued abnormal collagen crosslinking, rather than immediately restoring collagen that has already been fixed by glycation to a youthful structure.

 

Direction of action

Significance for glycation-related aging

Reducing oxidative stress

Reduces the conditions that promote further oxidation, rearrangement, and crosslinking of glycation intermediates

Chelating certain metal ions

Reduces the opportunity for iron, copper, and other metal ions to participate in redox catalysis

Supporting antioxidant regeneration cycles

Helps vitamin C, vitamin E, and GSH (glutathione) systems maintain reducing capacity

Assisting in carbonyl stress control

By supporting the cellular reducing environment, indirectly reduces the modification pressure exerted by reactive carbonyl compounds on proteins

 

7.2 Human Study: Improvement of Photoaging-Related Roughness with 5% α-Lipoic Acid

Topical 5% α-lipoic acid has some support from human research. A split-face controlled study enrolled 33 women: one side of each participant’s face was treated twice daily with a 5% α-lipoic acid cream, while the other side was treated with an identical vehicle cream without α-lipoic acid, for 12 weeks. The study used self-assessment, clinical evaluation, photographic assessment, and laser profilometry for observation. The results showed improvement in photoaging-related manifestations on the α-lipoic acid-treated side. Laser profilometry showed that average skin roughness decreased by 50.8% on the α-lipoic acid side and by 40.7% on the control side, with a statistically significant difference between the two sides.

 

These results support the potential of topical 5% α-lipoic acid to improve photoaging-related skin roughness, texture, and fine-line appearance. However, the study had a small sample size, and the control side also showed noticeable improvement, indicating that the cream vehicle, moisturization, and consistent use can also influence skin texture. This study did not directly measure skin AGEs, collagen glycation crosslinking, or carbonyl stress markers, and therefore cannot be considered strong evidence that topical α-lipoic acid has been clinically proven to be anti-glycation.

 

7.3 Formulation Positioning

 

Formulation positioning

Main role of α-lipoic acid

Antioxidant care

Participates in controlling reactive oxygen stress and reduces the impact of oxidative damage on skin structural proteins

Anti-glycation support

Reduces the driving effects of oxidative stress, metal catalysis, and carbonyl stress on AGE formation

Photoaging care

Topical research supports its potential benefits for photoaging-related roughness and fine-line appearance

Composite antioxidant system

Can form an antioxidant regeneration logic with systems related to vitamin C, vitamin E, and glutathione

Collagen environment protection

By reducing the damaging environment, helps reduce abnormal collagen crosslinking and degradation pressure

 

8. Representative Chemical Product Classification Tables Related to the Anti-Aging Mechanisms of α-Lipoic Acid

 

Table 1. Core Products Related to α-Lipoic Acid Structure and Redox Cycling

 

Category

CAS No.

Aladdin Cat. No.

Name

Specification or Purity

Product Features and Applications

Parent lipoic acid compound

1077-28-7

T106640

DL-Lipoic Acid

≥99%

Main racemic lipoic acid raw material, used in studies related to disulfide ring structure, redox cycling, antioxidant activity, and intervention in protein glycation

Chiral lipoic acid compound

1200-22-2

D118666

(R)-(+)-α-Lipoic Acid

Moligand™, ≥98%

Naturally configured lipoic acid, used for comparing the activity of chiral lipoic acid forms, studying mechanisms related to mitochondrial cofactors, and investigating intervention in oxidative and glycation stress

Reduced-form lipoic acid compound

462-20-4

D303763

Dihydrolipoic Acid

Moligand™, ≥97%

Reduced form of lipoic acid, used in studies of thiol-based reducing capacity, ascorbic acid regeneration, tocopherol regeneration, and glutathione cycling

Lipoylation-related compound

940-69-2

L124749

(±)-α-Lipoamide

Moligand™, ≥98%

Amide form of lipoic acid, used in studies of lipoylated cofactors, mitochondrial enzyme complexes, energy metabolism, and redox reactions

 

Table 2. Products for Glycation Reactions, Carbonyl Stress, Glycation Markers, and Anti-Glycation Research

 

Category

CAS No.

Aladdin Cat. No.

Name

Specification or Purity

Product Features and Applications

Glycation substrate

50-99-7

D755713

D-(+)-Glucose

Anhydrous grade, UltraBio™, ≥99.5% (HPLC), sum of enantiomers

Typical reducing sugar substrate, used in protein glycation models, Schiff base formation, Amadori product formation, and collagen glycation reaction studies

Glycation substrate

57-48-7

D755696

D-(-)-Fructose

UltraBio™, ≥99% (HPLC)

Reducing sugar substrate, used for comparing glycation reaction rates, protein glycation models, and glycation stress evaluation

Reactive dicarbonyl compound

107-22-2

G103130

Glyoxal Solution

Molecular biology grade, 40% in H2O (8.8 M)

Reactive dicarbonyl reagent, used in studies of protein carbonylation, lysine modification, and advanced glycation end product formation

Reactive dicarbonyl compound

78-98-8

M109035

Methylglyoxal

Moligand™, 40% solution

Methylglyoxal reagent, used in carbonyl stress models, protein modification studies, and evaluation of anti-carbonylation activity

Glycation intermediate

4084-27-9

D650932

3-Deoxyglucosone

—

Highly reactive glycation intermediate, used in studies of Amadori product degradation, carbonyl stress, and advanced glycation end product formation

Advanced glycation end product marker

5746-04-3

N695669

Nε-(1-Carboxymethyl)-L-lysine

≥98%

Non-fluorescent glycation marker, used in studies of protein glycoxidation, collagen glycation level, and glycation damage detection

Crosslinking glycation marker

124505-87-9

P351390

Pentosidine

—

Fluorescent crosslinking glycation marker, used in studies of collagen crosslinking, glycation-related yellowing, and skin aging indicator detection

Anti-carbonylation active compound

305-84-0

C106843

L-Carnosine

Moligand™, ≥98%

Dipeptide anti-carbonylation compound, used in studies of reactive carbonyl trapping, protein glycation inhibition, and collagen protection

Anti-glycation positive control

1937-19-5

A151036

Aminoguanidine Hydrochloride

Moligand™, ≥98% (T)

Classical anti-glycation research reagent, used for dicarbonyl compound trapping, advanced glycation end product inhibition, and positive control experiments

Anti-glycation positive control

2582-30-1

A111225

Aminoguanidine Bicarbonate

≥98.5%

Aminoguanidine salt reagent, used for carbonyl trapping, glycation reaction inhibition, and validation of anti-glycation mechanisms

Vitamin B6-related anti-glycation compound

85-87-0

P693320

Pyridoxamine

≥98%

Vitamin B6-related compound, used in studies of dicarbonyl compound intervention, metal-related glycoxidation reactions, and protein glycation inhibition

Vitamin B6-related anti-glycation compound

524-36-7

P111169

Pyridoxamine Dihydrochloride

≥98%

Salt form of pyridoxamine, used in studies of carbonyl stress intervention, glycoxidation inhibition, and anti-glycation activity evaluation

 

Table 3. Products Related to the Antioxidant Regeneration Network, Aqueous-Phase Antioxidation, and Lipid-Phase Antioxidation

 

Category

CAS No.

Aladdin Cat. No.

Name

Specification or Purity

Product Features and Applications

Prototype aqueous-phase antioxidant

50-81-7

L432793

L-Ascorbic Acid

Anhydrous grade, Moligand™, ACS, ≥99%

Representative water-soluble antioxidant, used in studies of ascorbic acid redox cycling, free radical scavenging, and tocopherol regeneration

Water-soluble stable ascorbic acid derivative

86404-04-8

O159940

3-O-Ethyl-L-ascorbic Acid

Moligand™, ≥98% (HPLC) (T)

Stable ascorbic acid derivative, used in studies of aqueous-phase antioxidation, ascorbic acid release, and skin-brightening-related evaluation

Water-soluble stable ascorbic acid derivative

113170-55-1

S160999

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate

Moligand™, ≥98% (HPLC)

Magnesium ascorbyl phosphate, used in stable ascorbic acid systems, aqueous-phase antioxidation, and cell-based experiments

Water-soluble stable ascorbic acid derivative

66170-10-3

S304311

Trisodium L-Ascorbate-2-Phosphate

≥96%

Sodium ascorbyl phosphate, used in aqueous-phase antioxidation, evaluation of stable ascorbic acid activity, and cell culture-related experiments

Water-soluble stable ascorbic acid derivative

129499-78-1

O160006

2-O-α-D-Glucopyranosyl-L-ascorbic Acid

≥98% (HPLC)

Ascorbyl glucoside, used in stable ascorbic acid systems, enzymatic release studies, and antioxidant activity research

Lipid-soluble ascorbic acid derivative

137-66-6

A104525

L-Ascorbyl Palmitate

PharmPure™, USP

Lipid-soluble ascorbic acid ester, used in lipid-environment antioxidation, ascorbic acid and tocopherol synergy, and oil-phase formulation research

Lipid-soluble ascorbic acid derivative

183476-82-6

A1519829

Ascorbyl Tetraisopalmitate

Cosmetic grade, ≥90%

Oil-soluble ascorbic acid derivative, used in lipid-phase antioxidation, skin lipid environments, and composite antioxidant formulation research

Prototype lipid-phase antioxidant

59-02-9

S161351

D-α-Tocopherol

Moligand™, ≥97% (GC)

Representative lipid-soluble antioxidant, used in studies of lipid peroxidation chain reaction inhibition, cell membrane protection, and antioxidant regeneration cycling

Stable tocopherol derivative

7695-91-2

D433817

DL-α-Tocopheryl Acetate

PharmPure™, European Pharmacopoeia (Ph. Eur.)

Stable tocopherol derivative, used in lipid-phase antioxidant formulations, skin conditioning, and tocopherol-related control studies

Glutathione reducing system

70-18-8

G774620

Glutathione, Reduced Form

PharmPure™, European Pharmacopoeia (Ph. Eur.)

Reduced glutathione, used in studies of the cellular reducing environment, peroxide clearance, carbonyl stress handling, and antioxidant cycling

Glutathione reducing system

27025-41-8

G105428

L-Glutathione, Oxidized Form

≥98%

Oxidized glutathione, used in studies of the glutathione redox ratio, cellular redox state, and antioxidant cycling

Lipid-phase quinone antioxidant

303-98-0

C111044

Coenzyme Q10

≥98%

Lipid-phase quinone antioxidant, used in studies of mitochondrial redox activity, lipid antioxidation, and cellular energy metabolism

Phenolic acid antioxidant

1135-24-6

F103701

Ferulic Acid

Moligand™, ≥99%

Phenolic acid antioxidant, used in studies of free radical scavenging, photo-oxidative protection, and antioxidant combination systems

Polyphenol antioxidant

501-36-0

R107315

Resveratrol

Moligand™, ≥99%

Polyphenol antioxidant, used in studies of oxidative stress regulation, photoaging-related research, and construction of composite antioxidant systems

 

Table 4. Products Related to Metal-Catalyzed Oxidation, Oxidative Stress Models, and Skin Structural Proteins

 

Category

CAS No.

Aladdin Cat. No.

Name

Specification or Purity

Product Features and Applications

Oxidative stress model compound

7722-84-1

H755825

Hydrogen Peroxide Solution

Suitable for microbiology, 3%

Oxidative stress-inducing reagent, used in peroxide stimulation, cellular oxidative damage, and antioxidant activity evaluation

Metal ion chelator

6381-92-6

E433190

Ethylenediaminetetraacetic Acid Disodium Salt Dihydrate

UltraBio™, ultrapure grade, ≥98.5%

Common metal ion chelator, used in metal-catalyzed oxidation control, formulation stabilization, and oxidative reaction intervention experiments

Polyphosphate metal chelator

83-86-3

P108521

Phytic Acid Solution

70% in H2O

Polyphosphate-structured chelator, used for binding iron, copper, and other metal ions, inhibiting metal-catalyzed oxidation, and formulation stabilization research

Polyphosphate metal chelator

14306-25-3

P775073

Phytic Acid Sodium Salt Hydrate

≥75%

Phytate chelator, used for aqueous-phase metal ion control, oxidative catalysis inhibition, and antioxidant formulation research

Collagen glycation model protein

9007-34-5

rp335221

Recombinant Humanized Type III Collagen

Animal-free, carrier-free, recombinant, ≥90% (SDS-PAGE), expressed in Nicotiana benthamiana

Collagen structural protein model, used in studies of collagen glycation, collagen crosslinking, structural aging, and collagen protection

Elastin aging model

9007-58-3

E754127

Porcine Elastin

≥90%

Elastic structural protein model, used in studies of elastin glycation, oxidative damage, loss of elasticity, and skin mechanical aging

 

Note: The above are representative Aladdin products related to scientific research and formulation studies. For more product specifications, grades, and COA information, please search by “product name / CAS / catalog number” on the Aladdin official website.

 

For more related articles, please see below:

 

Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling

 

Cosmetic Grade Explained

 

How to decipher the whitening code?

 

Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape

 

The "Six Key Checkpoints" of Skin Lightening

 

Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance

 

Glutathione (GSH) Quantification: Method Systems, Experimental Workflows, and Key Quality-Control Considerations

 

Glutathione Reductase: A Flavin-Dependent Reductive System Maintaining GSH/GSSG Homeostasis, with Assays and Applications

 

What is Glutathione?

 

What Is Glutathione Agarose?

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《The Skin Anti-Aging Mechanisms of α-Lipoic Acid: ALA/DHLA Redox Cycling, the Antioxidant Network, and Regulation of Collagen AGE Formation》. 阿拉丁知识库,更新于 2026年7月29日。 https://www.aladdin-e.com/zh_cn/faqs/the-skin-anti-aging-mechanisms-of-lipoic-acid-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助